MW
Margaret Faye Wilson
Director

Margaret Faye Wilson insider trades: Biocept (BIOC) stock purchases

Director, Biocept Last trade Oct 19, 2016 34 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2005
3
Companies
last trade 2016

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Margaret reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 19, 2016BIOC↑ Buy$15K
Mar 16, 2015BMR↑ Buy$50K
Feb 13, 2015BIOC↑ Buy$5K
Mar 9, 2009BMR↑ Buy$6K
Nov 11, 2008BMR↑ Buy$7K
Nov 27, 2007BMR↑ Buy$7K
Aug 30, 2007BMR↑ Buy$23K
May 16, 2006BMR↑ Buy$29K
Feb 22, 2006CMBC↑ Buy$43K
Jun 27, 2005BMR↑ Buy$23K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Margaret Faye Wilson's insider trades

Margaret Faye Wilson is a director at Biocept (BIOC). Since Jun 27, 2005, Margaret has reported 10 open-market purchases worth $208K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (21 filings), other transactions (4 filings), option exercises (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.